Private Advisor Group’s 9 Meters Biopharma NMTR Stock Holding History

Private Advisor Group’s Portfolio NMTR Stock Details NMTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,000	Closed	-$4K	–	2005
2022 Q3	$4K	Hold	1,000	–	–	﹤0.01%	1902
2022 Q2	$5K	Buy	1,000 +500	+100%	+$4.71K	﹤0.01%	2102
2022 Q1	$6K	Hold	500	–	–	﹤0.01%	2085
2021 Q4	$10K	Hold	500	–	–	﹤0.01%	2125
2021 Q3	$13K	Hold	500	–	–	﹤0.01%	2004
2021 Q2	$11K	Buy	+500	New	+$12.3K	﹤0.01%	1961

Other funds holding NMTR

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

ODFS

O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Private Advisor Group's NMTR Position: Q4 2022 in Review

Private Advisor Group sold out of 9 Meters Biopharma (NMTR) in Q4 2022, closing a stake of 1,000 shares — an estimated $4K sold.

Private Advisor Group first reported a position in NMTR in Q2 2021 and held it in 6 quarters. The position peaked at $13K in Q3 2021. 42 funds tracked by Wall St. Rank hold NMTR as of Q4 2022.

Private Advisor Group reported no remaining 9 Meters Biopharma position as of Q4 2022 after selling out during the quarter.
Private Advisor Group sold 1,000 9 Meters Biopharma shares in Q4 2022, an estimated $4K.
Private Advisor Group first reported a position in 9 Meters Biopharma in Q2 2021 and held it in 6 quarters.
Private Advisor Group's 9 Meters Biopharma position peaked at $13K in Q3 2021.
42 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2022.

Based on Private Advisor Group's 13F filing for Q4 2022, filed 18 Jan 2023.